%0 Journal Article
%T Targeted Peripheral Nerve-directed Onabotulinumtoxin A Injection for Effective Long-term Therapy for Migraine Headache
%A Jeffrey E. Janis
%A Jenny C. Barker
%A Marilly Palettas
%J Archive of "Plastic and Reconstructive Surgery Global Open".
%D 2017
%R 10.1097/GOX.0000000000001270
%X Onabotulinumtoxin A (BOTOX) is an FDA-approved treatment for chronic migraine headaches (MHs) that involves on-label, high-dose administration across 31 anatomic sites. Anatomically specific peripheral nerve trigger sites have been identified that contribute to MH pathogenesis and are amenable to both BOTOX injection and surgical decompression. These sites do not always correlate with the on-label FDA-approved injection pattern, but represent a more targeted approach. The efficacy of peripheral nerve¨Cdirected BOTOX injection as an independent long-term therapeutic option has not been investigated
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404453/